What is eazyScripts?
eazyScripts specializes in offering a leading ePrescribing solution tailored for telehealth organizations. Its platform facilitates rapid and customized drug orders, integrating seamlessly with various Electronic Health Record (EHR) systems to enhance the prescribing experience for medical professionals. The company emphasizes improving patient outcomes through features such as point-of-care pricing transparency and dedicated client support, aiming to simplify the adoption of electronic prescribing with a user-friendly interface that enables physicians to issue prescriptions in under 15 seconds. The company's focus on secure, HIPAA-compliant technology positions it as a key player in the evolving landscape of digital healthcare.
How much funding has eazyScripts raised?
eazyScripts has raised a total of $2M across 1 funding round:
Series A
$2M
Series A (2017): $2M with participation from Bluff Point Associates
Key Investors in eazyScripts
Bluff Point Associates
Bluff Point Associates is a private equity firm specializing in healthcare information services and financial services technology. Their investment in eazyScripts suggests a strategic focus on companies within the health tech sector that demonstrate strong growth potential and operational efficiency.
What's next for eazyScripts?
The substantial enterprise-level funding and recent strategic investment indicate eazyScripts is poised for significant scaling and market expansion. This capital infusion is likely to fuel further development of its ePrescribing platform, enhance integration capabilities with a broader range of EHR systems, and potentially expand its service offerings to address emerging needs in telehealth and remote patient monitoring. The company's commitment to user experience and regulatory compliance suggests a strategic focus on solidifying its market position and driving adoption among healthcare providers seeking efficient and secure digital prescribing tools.
See full eazyScripts company page
